Skip to content

Electrocardiographic and Cardiac Magnetic Resonance Predictors of Ventricular Arrhythmias in Cardiomyopathic Patients

ECG and CMR for Predicting PVCs in Cardiomyopathic Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05078125
Enrollment
79
Registered
2021-10-14
Start date
2022-04-01
Completion date
2023-03-30
Last updated
2022-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ventricular Complex

Brief summary

This study aims to assess ECG changes for predicting ventricular arrhythmia in cardiomyopathic patients

Detailed description

This study aims to assess ECG markers based on 24-hour Holter ECG recordings for predicting ventricular arrhythmia in patients with Structural Heart disease who have left ventricular dysfunction and Left Ventricular Ejection Fraction ≤40%. With special concerns to underlying structural abnormalities in cardiomyopathic patients using Cardiac Magnetic Resonance to determine ventricular function, scar distribution, and grey zone analysis

Interventions

24 hours Holter monitoring

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 70 Years

Inclusion criteria

* Patients with ischemic and non-ischemic cardiomyopathy, EF \< 40 % * Patient haemodynamically stable * Patients accept to make test

Exclusion criteria

1. Patients with underlying arrhythmia ex heart block or atrial arrhythmia like PACs, AF. 2. Patients on arrhythmogenic drugs ex digitalis, amiodarone. 3. Patients on underlying Pacemaker device or CRT-D. 4. Patients with MI in less than 40 days 5. Patients refuse to make test .

Design outcomes

Primary

MeasureTime frameDescription
Twenty-four hours Holter monitoring after Magnetic Resonance ImagingOne year24 Holter monitoring to detect PVCs burden which is defined as ≥10% of total beats

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026